← All Chemed CORP filings

Chemed CORP Form 4 insider transactions

NYSE
CHE
Chemed CORP
Form 4: CHEMED Director George Walsh III Buys Shares
CHEMED Corp. Director George J. Walsh III acquired 200 shares of company capital stock at $417.1 per share under a 10b5-1 plan.
NYSE
CHE
Chemed CORP
Form 4: CHEMED EVP Sells 10,012 Shares
Chemed Corp Executive Vice President Nicholas Westfall sold 10,012 shares of company capital stock for approximately $4.22 million.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director George J. Walsh III Acquires Shares
Director George J. Walsh III acquired 277 shares of Chemed Corp stock at $579.04 per share on May 19, 2025.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director Acquires Shares in Recent Transaction
John Meredith Mount Jr., a director at Chemed Corp, acquired 277 shares of capital stock at $579.04 per share on May 19, 2025.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director McCarthy Acquires 277 Shares of Capital Stock
Director Eileen P. McCarthy reports the acquisition of 277 shares of Chemed Corp capital stock on May 19, 2025.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director Andrea R. Lindell Acquires 277 Shares of Capital Stock
Director Andrea R. Lindell acquired 277 shares of Chemed Corp capital stock at $579.04 per share on May 19, 2025.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director Heaney Acquires 277 Shares of Capital Stock
Director Christopher J. Heaney acquired 277 shares of Chemed Corp capital stock at $579.04 per share on May 19, 2025, increasing his direct holdings to 2,389 shares.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director Patrick P. Grace Acquires 277 Shares of Capital Stock
Director Patrick P. Grace acquired 277 shares of Chemed Corp capital stock on May 19, 2025, at a price of $579.04 per share.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director Ron DeLyons Acquires 277 Shares of Capital Stock
Director Ron DeLyons acquired 277 shares of Chemed Corp capital stock at a price of $579.04 on May 19, 2025.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Vice President Spencer S. Lee Reports Sale of 1,500 Shares
Executive Vice President Spencer S. Lee of Chemed Corp. reports selling 1,500 shares of capital stock at an average price of $577.99 on May 16, 2025.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Vice President Nicholas Westfall Reports Stock Option Exercises and Disposals
Executive Vice President Nicholas Michael Westfall reports exercising stock options and disposing of shares of Chemed Corp on May 9, 2025.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Vice President Spencer S. Lee Sells 1,500 Shares
Executive Vice President Spencer S. Lee of Chemed Corp sold 1,500 shares of capital stock at an average price of $577.86 on May 7, 2025.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp CEO Kevin McNamara Reports Stock Option Exercise and Share Sales
Chemed Corp's CEO, Kevin McNamara, exercised stock options and sold shares on May 5, 2025, according to a Form 4 filing with the SEC.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp CEO Kevin J. McNamara Sells 1,000 Shares
Chemed Corp's CEO, Kevin J. McNamara, sold 1,000 shares of capital stock at an average price of $615.33 on March 31, 2025.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Exercises Stock Options and Sells Shares
Michael D. Witzeman, VP & Chief Financial Officer of Chemed Corp, exercised stock options and sold shares to cover the purchase price and tax obligations.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp CEO Kevin J. McNamara Sells 2,000 Shares
Chemed Corp's CEO, Kevin J. McNamara, sold 2,000 shares of capital stock at an average price of $593.67 on March 6, 2025.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Vice President Spencer S. Lee Reports Stock Sale
Executive Vice President Spencer S. Lee of Chemed Corp reports selling 1,326 shares of capital stock at an average price of $592.25 on March 3, 2025.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Spencer S. Lee Reports Stock Transactions
Executive Vice President Spencer S. Lee reports acquisition and disposal of Chemed Corp stock and performance stock units related to performance-based vesting.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Vice President Nicholas Westfall Reports Stock Transactions
Executive Vice President Nicholas Westfall reports the vesting and acquisition of Chemed Corp stock and performance stock units (PSUs) based on performance achievements, along with shares withheld for tax obligations.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Michael Witzeman Reports Stock Transactions Following PSU Vesting
VP & Chief Financial Officer of Chemed Corp, Michael D. Witzeman, reports acquisition and disposal of Chemed Capital Stock following the vesting of Performance Stock Units (PSUs).
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Thomas Hutton Reports Stock Transactions Following PSU Vesting
Chemed Corp's Vice President, Thomas C. Hutton, reports acquisition and disposal of company stock following the vesting of performance stock units (PSUs).
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp CEO Kevin McNamara Reports Stock Transactions Following PSU Vesting
Chemed Corp's CEO, Kevin McNamara, reports the vesting of performance stock units (PSUs) and subsequent stock transactions, including shares acquired, disposed of, and withheld for tax obligations.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Brian C. Judkins Reports Stock Transactions Following PSU Vesting
Brian C. Judkins, VP and Chief Legal Officer of Chemed Corp, reports the vesting and subsequent transactions of performance stock units (PSUs) based on company performance, along with the acquisition of new PSUs.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Brian C. Judkins Acquires Shares in Recent Transaction
Chemed Corp's VP and Chief Legal Officer, Brian C. Judkins, purchased 145 shares of company stock at $519.5 per share on December 30, 2024.
NYSE
CHE
Chemed CORP
4/A: Chemed Corp Executive Brian C. Judkins Reports Stock Transactions
Chemed Corp's VP and Chief Legal Officer, Brian C. Judkins, executed multiple transactions involving company stock and options on March 20, 2024, including the sale of 11,158 shares.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Vice President Sells 65 Shares of Capital Stock
Executive Vice President Spencer S. Lee of Chemed Corp sold 65 shares of capital stock on December 2, 2024.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Vice President Sells 732 Shares
Executive Vice President of Chemed Corp, Spencer S. Lee, sold 732 shares of company stock at a price of $575.623 per share on November 27, 2024.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp CEO Sells 2,000 Shares of Capital Stock
Chemed Corp's CEO, Kevin J. McNamara, sold 2,000 shares of capital stock at a weighted average price of $572.77 on November 25, 2024.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Vice President Sells 1,000 Shares
Executive Vice President of Chemed Corp, Spencer S. Lee, sold 1,000 shares of company stock at a price of $565.71 per share on November 22, 2024.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Executive Thomas C. Hutton Reports Stock Option Grant
Vice President Thomas C. Hutton of Chemed Corp reports the acquisition of stock options.